FDA Drug Application (062618) for ERYC by PARKE DAVIS

Back to FDA Applications sponsored by PARKE DAVIS

Application Number062618
Product Number001
FormCAPSULE, DELAYED REL PELLETS;ORAL
Dosage250MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameERYC
Active IngredientERYTHROMYCIN

Active IngredientCount
List of drugs with Active Ingredient ERYTHROMYCIN29


Back to FDA Applications sponsored by PARKE DAVIS